Fujimoto K - Search Results

1

Activation of coagulation by lenalidomide-based regimens for the treatment of multiple myeloma.

Isozumi Y, Arai R, Fujimoto K, Koyama T. Isozumi Y, et al. Among authors: fujimoto k. PLoS One. 2013 May 16;8(5):e64369. doi: 10.1371/journal.pone.0064369. Print 2013. PLoS One. 2013. PMID: 23696885 Free PMC article.

2

Release of salusin-beta from human monocytes/macrophages.

Sato K, Fujimoto K, Koyama T, Shichiri M. Sato K, et al. Among authors: fujimoto k. Regul Pept. 2010 Jun 8;162(1-3):68-72. doi: 10.1016/j.regpep.2010.02.010. Epub 2010 Feb 20. Regul Pept. 2010. PMID: 20176058

3

Acquired von Willebrand syndrome associated with Hashimoto's thyroiditis and subcutaneous mucosa-associated lymphoid tissue lymphoma.

Koyama T, Fujimoto K, Shima M. Koyama T, et al. Among authors: fujimoto k. Intern Med. 2013;52(23):2661-3. doi: 10.2169/internalmedicine.52.0825. Intern Med. 2013. PMID: 24292759 Free article.

4

Circulating levels of human salusin-β, a potent hemodynamic and atherogenesis regulator.

Fujimoto K, Hayashi A, Kamata Y, Ogawa A, Watanabe T, Ichikawa R, Iso Y, Koba S, Kobayashi Y, Koyama T, Shichiri M. Fujimoto K, et al. PLoS One. 2013 Oct 3;8(10):e76714. doi: 10.1371/journal.pone.0076714. eCollection 2013. PLoS One. 2013. PMID: 24098553 Free PMC article.

5

Emerging roles for vasoactive peptides in diagnostic and therapeutic strategies against atherosclerotic cardiovascular diseases.

Watanabe T, Sato K, Itoh F, Noguchi Y, Fujimoto K, Koyama T, Shichiri M. Watanabe T, et al. Among authors: fujimoto k. Curr Protein Pept Sci. 2013 Sep;14(6):472-80. doi: 10.2174/13892037113149990064. Curr Protein Pept Sci. 2013. PMID: 23968353 Review.

6

Physiological fluctuations of human plasma total salusin-β, an endogenous parasympathomimetic/proatherosclerotic peptide.

Ogawa A, Fujimoto K, Hayashi A, Chida S, Sato K, Takai K, Masaki T, Suzuki A, Kamata Y, Takano K, Koyama T, Shichiri M. Ogawa A, et al. Among authors: fujimoto k. Peptides. 2014 Sep;59:83-8. doi: 10.1016/j.peptides.2014.07.009. Epub 2014 Jul 22. Peptides. 2014. PMID: 25063054

7

GIP_HUMAN[22-51] is a new proatherogenic peptide identified by native plasma peptidomics.

Masaki T, Kodera Y, Terasaki M, Fujimoto K, Hirano T, Shichiri M. Masaki T, et al. Among authors: fujimoto k. Sci Rep. 2021 Jul 14;11(1):14470. doi: 10.1038/s41598-021-93862-w. Sci Rep. 2021. PMID: 34262109 Free PMC article.

8

Plasma and serum prorenin concentrations in diabetes, hypertension, and renal disease.

Kawamura S, Fujimoto K, Hayashi A, Kamata Y, Moriguchi I, Kobayashi N, Shichiri M. Kawamura S, et al. Among authors: fujimoto k. Hypertens Res. 2022 Dec;45(12):1977-1985. doi: 10.1038/s41440-022-00959-4. Epub 2022 Jun 10. Hypertens Res. 2022. PMID: 35689092

9

Routine Surveillance of Upper Urinary Tract Imaging for Diagnosing Upper Urinary Tract Urothelial Cancer Recurrence in Patients with Nonmuscle Invasive Bladder Cancer.

Nishimura N, Miyake M, Miyamoto T, Shimizu T, Fujii T, Morizawa Y, Hori S, Gotoh D, Nakai Y, Torimoto K, Tanaka N, Fujimoto K. Nishimura N, et al. Among authors: fujimoto k. Adv Urol. 2024 May 21;2024:5894288. doi: 10.1155/2024/5894288. eCollection 2024. Adv Urol. 2024. PMID: 38807901 Free PMC article.

10

Neuraminidase inhibition promotes the collective migration of neurons and recovery of brain function.

Matsumoto M, Matsushita K, Hane M, Wen C, Kurematsu C, Ota H, Bang Nguyen H, Quynh Thai T, Herranz-Pérez V, Sawada M, Fujimoto K, García-Verdugo JM, Kimura KD, Seki T, Sato C, Ohno N, Sawamoto K. Matsumoto M, et al. Among authors: fujimoto k. EMBO Mol Med. 2024 May 24. doi: 10.1038/s44321-024-00073-7. Online ahead of print. EMBO Mol Med. 2024. PMID: 38789599 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

4,072 results

Search Page